Kuick Molecular Diagnostic Platform for Rapid and Precise Point-of-Care COVID-19 Testing
Jun Ho Son, CTO, Kryptos Biotechnologies, Inc.
In this presentation, I will introduce a new and innovative molecular diagnostics platform, KuickTM, for rapid and precise Point-of-Care COVID-19 testing. The KuickTM
platform combines a solid-phase extraction (SPE) for highly
concentrated RNA from a patient sample and multiplexed photonic qPCR
technology for rapid and precise RNA amplification. The photonic qPCR,
which uses optical thin film as a heat converter and LED as a heat
source, can provides fast and highly sensitive multiplex RT-qPCR assay
within 15 minutes. Overall, a turnaround time for sample-in and
answer-out is less than 30 minutes for COVID-19 testing.
|
|
Add to Calendar ▼2022-03-01 00:00:002022-03-02 00:00:00Europe/LondonMicrofluidics to Address Pandemics - SARS-CoV-2 and BeyondMicrofluidics to Address Pandemics - SARS-CoV-2 and Beyond in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
